Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure

Conditions

• Acute-On-Chronic Liver Failure

Interventions

• COMBINATION_PRODUCT: Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification（4 hours）
• COMBINATION_PRODUCT: Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification（6 hours）
• COMBINATION_PRODUCT: Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification（8 hours）
• COMBINATION_PRODUCT: Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification（Multiple-treatment）

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

• [object Object]